Lelaidier C, de Ziegler D, Gaetano J, Hazout A, Fernandez H, Frydman R
Department of Obstetrics and Gynaecology, Hôpital A. Béclère, Clamart, France.
Hum Reprod. 1992 Nov;7(10):1353-6. doi: 10.1093/oxfordjournals.humrep.a137572.
In women having inactive ovaries, controlled preparation of the endometrium has been achieved with exogenous oestradiol and progesterone. We report on the feasibility and practicality of using a similar regimen for timing transfers of cryopreserved embryos in women whose ovaries have not been suppressed. A total of 91 women having cryopreserved embryos from previous in-vitro fertilization (IVF) attempts received 4 mg/day of oestradiol valerate, starting on cycle day 1 of spontaneous (n = 85) or induced (n = 6) menstruation. A single blood sample was obtained on cycle day 14 for the measurement of plasma progesterone, oestradiol and luteinizing hormone (LH). Vaginal administration of micronized progesterone (300 mg/day) was started on day 15. Cryopreserved embryos were transferred on day 17 or 18 provided that day 14 plasma progesterone remained < or = 0.5 ng/ml, thereby confirming the absence of spontaneous ovulation prior to the administration of exogenous progesterone. Out of 91 cycles studied, plasma progesterone was found to be elevated (> 1 ng/ml) in only three (3.2%). Of the 88 scheduled transfers, 31 did not take place because no embryo survived thawing. In the remaining 57 cycles, 116 embryos were transferred resulting in 10 pregnancies, giving pregnancy and embryo implantation rates of 17.5 and 8.6% respectively. When a positive beta human chorionic gonadotrophin (HCG) titre was obtained, supplementation with oral oestradiol and vaginal progesterone was continued until placental autonomy was achieved. Of the 10 pregnancies, five (50%) were lost during the first trimester (biochemical, n = 1; miscarriage, n = 3; ectopic, n = 1).(ABSTRACT TRUNCATED AT 250 WORDS)
对于卵巢无活性的女性,可通过外源性雌二醇和孕酮实现子宫内膜的控制性准备。我们报告了在未抑制卵巢功能的女性中,使用类似方案来安排冷冻胚胎移植时间的可行性和实用性。共有91名曾接受体外受精(IVF)并冷冻胚胎的女性,从自发月经周期第1天(n = 85)或诱导月经周期第1天(n = 6)开始,接受4毫克/天的戊酸雌二醇治疗。在周期第14天采集一份血样,用于检测血浆孕酮、雌二醇和促黄体生成素(LH)。在第15天开始经阴道给予微粒化孕酮(300毫克/天)。若第14天血浆孕酮≤0.5纳克/毫升,确认在给予外源性孕酮之前未发生自发排卵,则在第17天或18天进行冷冻胚胎移植。在研究的91个周期中,仅3个周期(3.2%)的血浆孕酮升高(>1纳克/毫升)。在计划的88次移植中,31次未进行,因为没有胚胎解冻后存活。在其余57个周期中,移植了116个胚胎,结果有10例妊娠,妊娠率和胚胎着床率分别为17.5%和8.6%。当β人绒毛膜促性腺激素(HCG)检测呈阳性时,继续口服雌二醇和经阴道给予孕酮,直至胎盘功能自主。在这10例妊娠中,5例(50%)在孕早期丢失(生化妊娠,n = 1;流产,n = 3;异位妊娠,n = 1)。(摘要截短于250字)